AarogyaAI and TB treatment in India

TB is a major health problem that causes 220,000 deaths every year in India. AarogyaAI Innovations uses AI to diagnose the drug resistance in TB and offer practical solutions against it.

After Covid-19, the second deadliest disease taking the lives of millions is Tuberculosis (TB). TB is a major health problem that causes 220,000 deaths every year in India. Despite the severity of the disease and the number of people affected by it, the way of treatment for TB is to prescribe a range of antibiotics. This method of treatment stretched the years of treatment for TB. The long years will put a tremendous burden on one’s mental and physical health along with their finances. Worse is that over time, the treatments become less effective causing drug resistance. Making all their efforts go down the drain.

To change this cocktail drug approach in TB treatment, Dr Praapti Jayaswal and Avlokita Tiwari came together with AarogyaAI Innovations. Dr Jayaswal has more than a decade worth of research knowledge. She holds a PhD in tuberculosis research from the Translational Health Science and Technology Institute in New Delhi. Along with that, she has also spent some time in the All Indian Institute of Medical Sciences (AIIMS). Tiwari has completed her MS in Bioinformatics from the University of Turku in Finland. She is responsible to bridge the gap between technology and biology in the company. 

This Delhi-based venture uses AI to diagnose the drug resistance in TB and offer a list of drug combinations that work or wouldn’t work in favour of the patient. This method of drug prescription can lower the treatment duration to less than 6 months. The idea was first pitched to a UK-based incubator, Entrepreneur First. Later they got tuberculosis physician and WHO Chief Scientist, Dr Soumya Swaminathan, onboard as an advisor. In 2019, they were the best pitch at Shakti Challenge for Women. A year later, they won the BIRAC TiE WInER (Women in Entrepreneurial Research) Award.

Their software is expected to commercially be available by mid-2022. They have established partnerships with  Genotypic, CCAMP Lifeline Laboratories, Indian Spinal injuries Centre, Sir Gangaram Hospital, Foundation of Medical Research and IQVIA. In 2020, they had received $55,000 as seed fund. This year, on January 7th, they received $700,000 from Redstart Labs, Avaana Capital, Entrepreneur First, First In Ventures and Info Edge. With these funds, will AarogyaAI Innovations be able to make TB treatment more effective in India?

Tags : #AarogyaAIInnovations #DrPraaptiJayaswal #AvlokitaTiwari #EntrepreneurFirst #RedstartLabs #AvaanaCapital #FirstInVentures #InfoEdge #Genotypic #CCAMP #LifelineLaboratories #IndianSpinalInjuriesCentre #SirGangaramHospital #FoundationofMedicalResearch #IQVIA #MediSpeak #smitakumar #medicircle

About the Author

Priyal Shah

Priyal Shah is a graduate of Media from Mithibai College, Mumbai. She is a writer, researcher and avid reader.

Related Stories

Loading Please wait...

Trending Now

PM addresses the Nation today, announces free vaccinesJune 07, 2021
Why inhalers are best for treating asthma, well illustrated by Dr. Anil SingalMay 12, 2021
Dr. Rohan Palshetkar shares his invaluable insights about the Maternal Mortality Rate causes and improvements in India April 29, 2021
It is important to adopt a non-judgmental attitude towards any teenage girl seeking contraceptive advise suggests Dr. Teena Trivedi, Obstetrician and GynecologistApril 16, 2021
80% of the diseases are psychosomatic which means they have roots in the mind and this is where homeopathy steps in - It resolves physical ailments by finding the cause in the mind – Dr. Sanket Dhuri, Consultant Homeopath April 14, 2021
A futuristic Vision of a Healthcare Entrepreneur: Shyatto Raha, CEO, and Founder of MyHealthcareApril 12, 2021
Saher Mehdi, Founder and Chief Scientist at wellOwise talks about aspects making healthcare more equitable and reachableApril 10, 2021
Wide variety of therapies to address autism in children explained by Dr. Shilpa Jasubhai, Clinical PsychologistApril 09, 2021
Allopathic and Homeopathic medicines should not be taken together says Dr. Sunil Mehra, Homeopath ConsultantApril 08, 2021
The charm of homeopathic medicine is that it can be taken with conventional medicines – Dr. Shruthi Shridhar, Consulting Homeopath April 08, 2021
Dissociative Identity Disorder and associated concepts explained by Dr. Vinod Kumar, Psychiatrist and Head of Mpower - The Centre (Bangalore) April 07, 2021
Dissociative Identity Disorder explained by Dr. Shilpa Jasubhai, Clinical PsychologistApril 05, 2021
Sehat Ki Baat, Karishma Ke Saath- Episode 6 Healthy Diet For Boosting Metabolism Which Can Help Thyroid Patients April 03, 2021
Significant Pointers on Kidney Health by Dr. Santosh Waigankar, Consultant Urooncologist and Robotic Surgeon at Kokilaben Dhirubhai Ambani HospitalApril 01, 2021
Dr. Vaishal Kenia, Ophthalmologist Talks About the Different Possibilities Available for the Treatment of Glaucoma Depending Upon Their Type and SeverityMarch 30, 2021
No Definitive Role of Diet in Treatment of Lymphedema but Intake of Calories, Salt and Long Chain Fatty Acids should be controlled says Dr. Ramani CVMarch 30, 2021
Dr. Kiran Chandra Patro, Senior Nephrologist Talks About Dialysis as the Temporary Process and Not a Permanent Cure for the Patients of Renal DysfunctionMarch 30, 2021
Two out of three new chronic kidney disease patients are found to have diabetes or hypertension informs Dr. Sreeharsha HarinathaMarch 30, 2021
Glaucoma Treatment: Medications or Surgery? A valuable piece of advice from Dr. Pranay Kapdia, Chairman and Medical Director of Kapadia Eye CareMarch 25, 2021
Dr. Shraddha Satav, Consultant Ophthalmologist Recommends that Everybody After 40, Should Go for the Complete Eye Checkup at Regular IntervalMarch 25, 2021